Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Specimen Handling × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 32 Leukemia, Myeloid, Acute 28 Lung Neoplasms 27 Prostatic Neoplasms 23 Carcinoma, Non-Small-Cell Lung 23 Colorectal Neoplasms 20 Multiple Myeloma 17 Urinary Bladder Neoplasms 13 Ovarian Neoplasms 13 Melanoma 13 Breast Neoplasms 13 Triple Negative Breast Neoplasms 12 Carcinoma, Renal Cell 12 Squamous Cell Carcinoma of Head and Neck 11 Pancreatic Neoplasms 11 Endometrial Neoplasms 11 Mouth Neoplasms 10 Lymphoma 10 Laryngeal Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma, Transitional Cell 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Burkitt Lymphoma 9 Myeloproliferative Disorders 8 Lymphoma, Large B-Cell, Diffuse 8 Hypopharyngeal Neoplasms 8 Glioblastoma 8 Oropharyngeal Neoplasms 7 Myelodysplastic-Myeloproliferative Diseases 7

Interventions

Cisplatin 4 Platinum 3 Pemetrexed 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 tremelimumab 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cediranib 1 atezolizumab 1 aldesleukin 1 Radiotherapy 1 Radiation 1 Pharmaceutical Preparations 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡